COPD Clinical Trials in Chengdu, Sichuan
6 recruitingChengdu, Sichuan, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.
COPD
Guangdong Hengrui Pharmaceutical Co., Ltd160 enrolled1 locationNCT07116915
Recruiting
Phase 2
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.360 enrolled51 locationsNCT07292714
Recruiting
Chronic Airway Disease and Multimorbidity Cohort
AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis
China-Japan Friendship Hospital2,000 enrolled9 locationsNCT06798077
Recruiting
Phase 1
A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.72 enrolled1 locationNCT06748079
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD
Chronic Obstructive Pulmonary Disease (COPD)
Haisco Pharmaceutical Group Co., Ltd.474 enrolled2 locationsNCT06643078
Recruiting
Not Applicable
Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD
COPD
Hangzhou Broncus Medical Co., Ltd.200 enrolled1 locationNCT05799664